substance p has been researched along with Itching in 129 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.10) | 18.7374 |
1990's | 10 (7.75) | 18.2507 |
2000's | 48 (37.21) | 29.6817 |
2010's | 62 (48.06) | 24.3611 |
2020's | 5 (3.88) | 2.80 |
Authors | Studies |
---|---|
Bountouvas, A; Carstens, E; Domocos, D; Follansbee, T; Iodi Carstens, M; Nguyen, A; Nguyen, E; Ross, SE; Takanami, K; Velasquez, L | 1 |
Chen, H; Ge, W; Huang, Y; Jiang, J; Jin, Z; Kong, Y; Li, F; Li, L; Li, M; Liu, X; Zeng, X; Zhanmu, O | 1 |
Garces, JC; Ingrasci, G; Lipman, ZM; Loayza, E; Maldonado, C; Nattkemper, LA; Yosipovitch, G | 1 |
Bäumer, W; Fukuyama, T; Ganchingco, JRC; Yoder, JA | 1 |
Ahluwalia, A; Ingram, JR | 1 |
Metz, M | 1 |
Buscaglia, P; Fouyet, S; L'Herondelle, K; Le Gall-Ianotto, C; Le Garrec, R; Leschiera, R; Lewis, RJ; Michel, L; Mignen, O; Misery, L; Philippe, R; Pierre, O; Talagas, M | 1 |
Dang, NH; Hatano, R; Itoh, T; Kimura, U; Komiya, E; Morimoto, C; Ohnuma, K; Otsuka, H; Suga, Y; Takamori, K; Tominaga, M; Yamada, T; Yamazaki, H | 1 |
Azimi, E; Graham, TA; Lerner, EA; Reddy, VB | 1 |
Eirefelt, S; Hawro, T; Hoey, G; Koopmann, W; Maurer, M; Metz, M; Ohanyan, T; Schoepke, N | 1 |
Honda, T; Kabashima, K; Kitayama, N; Nakashima, C; Nonomura, Y; Otsuka, A; Usui, K; Wong, LS; Yamamoto, Y | 1 |
Bradley, M; Hall, MA; Heilborn, J; Holmberg, J; Holst, M; Killasli, H; Lönndahl, L; Nordlind, K; Theodorsson, E | 1 |
Choi, H; Chung, E; Hong, HS; Hwang, JS; Kim, DJ; Lim, S; Nam, S; Park, KS; Shin, MK; Son, Y; Won, Y | 1 |
Ahn, HJ; Choi, HW; Kim, KS; Shin, MK; Son, YS | 1 |
Andoh, T; Asakawa, Y; Kuraishi, Y | 1 |
Duvic, M; Huang, S; Lewis, DJ | 1 |
Carrion, AF; Levy, C; Rosen, JD | 1 |
Ständer, S; Yosipovitch, G | 1 |
Fayne, RA; Hashimoto, T; Kursewicz, CD; Nanda, S; Nattkemper, L; Shah, SM; Yokozeki, H; Yosipovitch, G | 1 |
Basbaum, AI; Eberhart, D; Meda, K; Rice, D; Solorzano, C; Urban, R; Wang, X; Yamanaka, H; Zhang, J | 1 |
Dwornicki, M; Gawlik, R; Grabiec, P; Grzeszczak, W; Kuźniewicz, R; Owczarek, A; Snit, M; Walaszczyk, M; Łącka-Gaździk, B | 1 |
Akiyama, T; Carstens, E; Carstens, MI; Takamori, K; Tominaga, M | 1 |
Funahashi, H; Ikeda, T; Matsushima, O; Naono-Nakayama, R; Nishimori, T; Sameshima, H; Takamiya, K | 1 |
Edvinsson, L; Wallengren, J | 1 |
Cho, SI; Choi, MG; Choi, YH; Kim, HO; Kwak, IS; Park, CW; Yang, YS | 1 |
Lotts, T; Ständer, S | 1 |
Choi, YH; Jang, YC; Kwak, IS; Lee, YK | 1 |
Ebihara, K; Funahashi, H; Ikeda, T; Ishida, Y; Koganemaru, G; Kuramashi, A; Naono-Nakayama, R; Nishimori, T | 1 |
Fisher, A; Ratti, E; Trower, MK; Upton, N | 1 |
Condjella, RM; Conley, O; Dahl, MV; Fryer, AD; Jacoby, DB; Jacoby, NW; Kloeber, JA; Lee, JJ; Lee, NA; Luo, H; Maizer, P; Mazzolini, A; Neely, JL; Ochkur, SI; Patel, YS; Protheroe, CA; Raish, RJ; Scott, GD; Vega, ML; Zellner, KR | 1 |
Andersen, HH; Kullander, K; Lagerström, MC; Rogoz, K | 1 |
Weber, HC | 1 |
Bettelini, L; Corsi, M; Costantini, VJ; Dünstl, G; Gerrard, P; Zonzini, L | 1 |
Arimura, A; Deguchi, M; Furue, Y; Haruna, T; Hikita, I; Ikeda, M; Imura, C; Imura, K; Morioka, Y; Shichijo, M; Soga, M; Yamamoto, M; Yamauchi, A; Yasui, K | 1 |
Ding, H; Hayashida, K; Kimura, M; Ko, MC; Mendenhall, V; Sukhtankar, DD; Suto, T | 1 |
Dijkstra, JF; Duraku, LS; Holstege, JC; Schüttenhelm, BN; Walbeehm, ET | 1 |
Luger, TA; Ständer, S | 2 |
Barry, DM; Chen, XJ; Chen, ZF; Li, H; Li, YQ; Liu, XT; Liu, XY; Munanairi, A; Shen, KF; Sun, YG; Wu, ZY; Yin, J | 1 |
Anthony, RM; Azimi, E; Lerner, EA; Pereira, PJS; Reddy, VB; Shade, KC; Talbot, S | 1 |
Agelopoulos, K; Loser, K; Lotts, T; Luger, TA; Phan, NQ; Schmaus, G; Ständer, S | 1 |
Azimi, E; Lerner, EA; Pereira, PJS; Reddy, VB; Talbot, S; Woolf, CJ | 1 |
Funahashi, H; Igawa, K; Ishida, Y; Matsuo, H; Miyahara, Y; Naono-Nakayama, R; Nishimori, T; Sakoda, S; Yamashita, Y | 1 |
Chau, NG; Kupper, TS; LeBoeuf, NR; Song, JS; Tawa, M | 1 |
Carr, MN; Koch, SN; Reiter, LV; Torres, SM | 1 |
Ko, MC; Naughton, NN | 1 |
Furue, M; Hosokawa, C; Takeuchi, S | 1 |
Oda, M; Sato, H; Suwa, E; Suzuki, M; Ueno, K; Yamaura, K | 1 |
Sato, S; Yoshizaki, A | 1 |
Chikumoto, T; Igeta, K; Inagaki, N; Itoh, T; Katoh, H; Kim, JF; Nagai, H; Nagao, M; Shiraishi, N; Tanaka, H | 1 |
Ikeda, T; Naono-Nakayama, R; Nishimori, T; Sunakawa, N | 1 |
Kawana, S; Yamaoka, J; Yilinuer, H | 1 |
Amatya, B; Nordlind, K; Wahlgren, CF | 1 |
Carstens, EE; Carstens, MI; Jinks, SL; Simons, CT | 1 |
Böhm, M; Capellino, S; Haas, S; Luger, TA; Phan, NQ; Ständer, S; Straub, RH | 1 |
Andoh, T; Hattori, M; Konno, M; Kuraishi, Y; Lee, JB; Zhang, Q | 1 |
Blass, GR; Lewin, GR; Park, TJ; Smith, ES | 1 |
Namiki, T; Suzuki, M; Ueno, K; Yamaura, K | 1 |
Bae, BG; Lee, KH; Noh, JY; Oh, SH; Park, CO; Park, IH; Wu, WH | 1 |
Buhren, BA; Gerber, PA; Homey, B | 1 |
Bito, T; Fukamachi, S; Kabashima, K; Kobayashi, M; Kuroda, E; Mori, T; Nakamura, M; Sakabe, J; Shiraishi, N; Tokura, Y | 1 |
Carlson Scholz, JA; Deng, Y; Franklin, R; Smith, PC; Williams-Fritze, MJ; Wilson, SR; Zeiss, C | 1 |
Metz, M; Raap, U; Ständer, S | 1 |
Akasaka, Y; Hatta, A; Inoue, H; Tsukahara, M; Yoshida, T | 1 |
Amiri, M; Beiraghdar, F; Davoudi, SM; Hoseininejad, SL; Kolivand, M; Panahi, Y; Sahebkar, A | 1 |
Ferguson, MWJ; Henderson, J; Terenghi, G | 1 |
Silberstein, M | 1 |
Cynkier, A; Danilewicz, M; Erkiert-Polguj, A; Stasikowska-Kanicka, O; Sysa-Jędrzejowska, A; Wągrowska-Danilewicz, M; Waszczykowska, E; Zebrowska, A | 1 |
Davoudi, SM; Panahi, Y; Ranjbar, R; Sahebkar, A; Taherzadeh, ES | 1 |
Abd El-Latif, MI; Izumi, M; Katayama, I; Matsui, S; Murota, H; Nishioka, M; Sano, S; Tani, M; Terao, M | 1 |
Honda, T; Mochizuki, H; Momen, S; Nakao, K; Okano, K; Sakakibara, S; Tanaka, T; Togashi, Y; Umeuchi, H | 1 |
Hawro, T; Lesiak, A; Narbutt, J; Olejniczak, I; Sobolewska-Sztychny, D; Sysa-Jedrzejowska, A; Słowik-Kwiatkowska, I | 1 |
Akiyama, T; Blansit, K; Carstens, E; Carstens, MI; Davoodi, A; Horwitz, A; Nagamine, M; Tominaga, M | 1 |
Andoh, T; Kuraishi, Y | 4 |
Carstens, E; Cuellar, JM; Jinks, SL; Simons, CT | 1 |
Al-Akeel, A; Andoh, T; Honma, Y; Kawaharada, S; Kuraishi, Y; Nojima, H | 1 |
Hossen, MA; Kamei, C; Kayasuga, R; Sugimoto, Y | 1 |
Honda, T; Nagase, H; Nakao, K; Okano, K; Tanaka, T; Togashi, Y; Umeuchi, H | 1 |
Al-Akeel, A; Andoh, T; Kuraishi, Y; Nojima, H; Tsujii, K | 1 |
Artuc, M; Brzoska, T; Buddenkotte, J; Henz, BM; Lippert, U; Luger, TA; Metze, D; Moormann, C; Schumacher, M; Shpacovitch, V; Ständer, S; Steinhoff, M | 1 |
English, KB; Johansson, O; Saffle, JR; Tuckett, RP; Ward, RS | 1 |
Hayashi, T; Jung, B; Konomi, A; Ohmura, T; Satoh, H; Satoh, Y | 1 |
Ebata, T | 1 |
Ikeda, M; Kodama, H; Ohtsu, H; Seike, M; Terui, T | 1 |
Ben Smail, D; Bussel, B; Denys, P; Hugeron, C | 1 |
Kim, DH; Shin, YW | 1 |
Fujii, Y; Hossen, MA; Inoue, T; Kamei, C; Shinmei, Y; Watanabe, T | 1 |
Andoh, T | 2 |
Hosogi, M; Ikoma, A; Miyachi, Y; Schmelz, M | 1 |
Brain, SD; Costa, SK; Gilmore, D; Hyslop, S; Starr, A | 1 |
Hamada, R; Ikeda, M; Kamijima, R; Kodama, H; Ohtsu, H; Seike, M | 1 |
Bady, P; Baumann, T; Bigliardi, PL; Bigliardi-Qi, M; Gaveriaux-Ruff, C; Kieffer, BL; Pfaltz, K; Rufli, T | 1 |
Di, ZH; Kawana, S; Sun, W; Yamaoka, J | 2 |
Lonne-Rahm, S; Nordlind, K; Remröd, C | 1 |
Akiyama, H; Amano, H; Ishikawa, O; Negishi, I | 1 |
Bíró, T; Dobrosi, N; Géczy, T; Marincsák, R; Paus, R; Tóth, BI | 1 |
Aki, T; Hashimoto, K; Hide, M; Kawamoto, S; Onishi, N; Ono, K; Santo, H; Shigeta, S; Suzuki, H | 1 |
Kawana, S; Yamaoka, J | 2 |
Hon, KL; Lam, MC; Leung, TF; Ng, PC; Wong, KY | 1 |
Baran, E; Salomon, J | 1 |
Andoh, T; Kosaka, M; Kuraishi, Y; Lee, JB; Nakano, T; Tayama, M | 1 |
Fjellner, B; Hägermark, O | 1 |
Hartschuh, W; Reinecke, M; Weihe, E | 1 |
Ekblom, A; Lundeberg, T; Wahlgren, CF | 1 |
Lotti, T; Teofoli, P; Tsampau, D | 1 |
Hayashi, K; Kuraishi, Y; Nagasawa, T; Satoh, M | 1 |
Berberian, B; Dodd, WA; Ellis, CN; Jarratt, MT; Katz, HI; Krueger, G; Prawer, S; Rex, IH; Sulica, VI; Wolf, JE | 1 |
Handwerker, HO; Heyer, G; Schmitz, J; Ulmer, FJ | 1 |
Cremer, B; Czarnetzki, BM; Dippel, E; Heimann, A | 1 |
Boehncke, WH; Gall, H; Kaufmann, R; Schultz, KD | 1 |
Cho, YL; Huang, TP; Liu, HN; Tarng, DC | 1 |
Andoh, T; Kuraishi, Y; Nagasawa, T; Satoh, M | 1 |
Kakihara, Y; Komatsu, K; Kuraishi, Y; Tohda, C | 1 |
Kaneko, M; Kawakita, T; Kuraishi, Y; Maekawa, T; Miyamoto, T; Nishikawa, Y; Nojima, H; Yamaguchi, T | 1 |
Luger, T; Metze, D; Ständer, S | 1 |
Marsella, R; Nicklin, CF | 1 |
Ando, N; Endoh, T; Honda, T; Kamei, J; Kawamura, K; Nagase, H; Okano, K; Tanaka, T; Togashi, Y; Umeuchi, H; Utsumi, J; Yoshizawa, Y | 1 |
Andoh, T; Katsube, N; Kuraishi, Y; Maruyama, M | 1 |
Culhaci, N; Dikicioğlu, E; Karaman, G; Savk, E; Sendur, N | 1 |
Marsella, R; Melloy, C; Nicklin, CF | 1 |
Fujita, Y; Kaku, H; Kawakubo, H; Naka, F; Nakano, K; Nishikawa, K; Suehiro, S; Yago, H | 1 |
Mygind, N; Schaffalitzky de Muckadell, OB; Tønnesen, P | 1 |
Bernstein, JE | 1 |
14 review(s) available for substance p and Itching
Article | Year |
---|---|
Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma.
Topics: Analgesics, Opioid; Histamine; Humans; Interleukins; Lymphoma, T-Cell, Cutaneous; Nerve Growth Factor; Nicotinamide Phosphoribosyltransferase; Pruritus; Substance P | 2018 |
Understanding and Treating Pruritus in Primary Biliary Cholangitis.
Topics: Anion Exchange Resins; Bile Acids and Salts; Cholestyramine Resin; Drainage; Filtration; Humans; Liver Cirrhosis, Biliary; Lysophospholipids; Narcotic Antagonists; Opioid Peptides; Phosphoric Diester Hydrolases; Plasmapheresis; Pruritus; Receptors, Opioid; Rifampin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance P | 2018 |
Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.
Topics: Animals; Chronic Disease; Clinical Trials, Phase II as Topic; Disease Models, Animal; Humans; Molecular Targeted Therapy; Neurokinin-1 Receptor Antagonists; Pruritus; Quality of Life; Receptors, Neurokinin-1; Severity of Illness Index; Signal Transduction; Skin; Substance P; Treatment Outcome | 2019 |
Research in practice: substance P antagonism in chronic pruritus.
Topics: Anti-Inflammatory Agents; Chronic Disease; Cytokines; Dermatologic Agents; Evidence-Based Medicine; Humans; Models, Immunological; Pruritus; Skin; Substance P | 2014 |
Gastrointestinal peptides and itch sensation.
Topics: Gastrin-Releasing Peptide; Humans; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Pruritus; Signal Transduction; Spinal Cord; Substance P | 2015 |
NK-1 Antagonists and Itch.
Topics: Animals; Aprepitant; Humans; Morpholines; Pruritus; Receptors, Neurokinin-1; Substance P | 2015 |
Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.
Topics: Adult; Aged; Aprepitant; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Morpholines; Neurokinin-1 Receptor Antagonists; Protein Binding; Pruritus; Substance P | 2017 |
[Expression of the histamine H4 receptor in human tissues and its clinical role].
Topics: Animals; Arthritis, Rheumatoid; Cell Differentiation; Histamine Antagonists; Humans; Keratinocytes; Pruritus; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Skin; Substance P; Synovial Membrane | 2010 |
Pathophysiology of itch and new treatments.
Topics: Anti-Allergic Agents; Brain-Derived Neurotrophic Factor; Histamine; Humans; Interleukins; Keratinocytes; Mast Cells; Nerve Growth Factor; Neurokinin-1 Receptor Antagonists; Neurons; Pruritus; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Skin; Substance P | 2011 |
[Generalized pruritus in hemodialysis patients].
Topics: Cytokines; Histamine Release; Humans; Kidney Failure, Chronic; Mast Cells; Opioid Peptides; Pruritus; Renal Dialysis; Substance P | 2004 |
[Importance of epidermal keratinocytes in itching].
Topics: Animals; Disease Models, Animal; Drug Design; Epidermal Cells; Histamine Release; Humans; Keratinocytes; Leukotriene B4; Mast Cells; Mice; Nitric Oxide; Pruritus; Receptor, PAR-2; Substance P | 2006 |
TRP channels as novel players in the pathogenesis and therapy of itch.
Topics: Animals; Cannabinoids; Capsaicin; Central Nervous System; Histamine; Humans; Inflammation Mediators; Nerve Growth Factors; Neurons; Neurons, Afferent; Neuropeptides; Pain; Pruritus; Spinal Cord; Substance P; Temperature; Transient Receptor Potential Channels; TRPV Cation Channels | 2007 |
[Mechanisms of cutaneous itch: new itch mediators and enhancement factors produced by keratinocytes].
Topics: Animals; Autocrine Communication; Drug Design; Free Radicals; Histamine; Humans; Hydrogen Peroxide; Immunoglobulin E; Keratinocytes; Leukotriene B4; Mast Cells; Nitric Oxide; Pruritus; Receptors, IgG; Substance P; Thromboxane A2 | 2008 |
Capsaicin in dermatologic disease.
Topics: Capsaicin; Humans; Middle Aged; Neuralgia; Pruritus; Skin Diseases; Substance P | 1988 |
10 trial(s) available for substance p and Itching
Article | Year |
---|---|
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.
Topics: Administration, Cutaneous; Aged; Aprepitant; Case-Control Studies; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Neurokinin-1 Receptor Antagonists; Proof of Concept Study; Prospective Studies; Prurigo; Pruritus; Receptors, Neurokinin-1; Severity of Illness Index; Substance P; Visual Analog Scale | 2018 |
Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis.
Topics: Administration, Cutaneous; Adult; Antipruritics; Aprepitant; Dermatitis, Atopic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Neurokinin-1 Receptor Antagonists; Pruritus; Severity of Illness Index; Skin; Substance P; Sweden; Time Factors; Treatment Outcome; Young Adult | 2018 |
Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride.
Topics: Administration, Oral; Administration, Topical; Adult; Dermatitis, Atopic; Dibenzoxepins; Drug Synergism; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Olopatadine Hydrochloride; Pruritus; Substance P; Young Adult | 2009 |
Responses to intradermal injections of substance P in psoriasis patients with pruritus.
Topics: Adult; Area Under Curve; Case-Control Studies; Double-Blind Method; Female; Histamine; Humans; Injections, Intradermal; Male; Middle Aged; Pruritus; Psoriasis; Severity of Illness Index; Substance P; Time Factors | 2010 |
Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Antioxidants; Antipruritics; Chemical Warfare Agents; Chronic Disease; Curcumin; Dietary Supplements; Double-Blind Method; Humans; Iran; Irritants; Male; Middle Aged; Mustard Gas; Oxidoreductases; Pruritus; Quality of Life; Severity of Illness Index; Substance P; Surveys and Questionnaires; Veterans | 2012 |
Treatment of aquagenic pruritus with topical capsaicin cream.
Topics: Administration, Topical; Capsaicin; Double-Blind Method; Female; Fluorescent Antibody Technique; Humans; Male; Nerve Fibers; Neuropeptides; Pruritus; Skin; Substance P; Water | 1994 |
A double-blind evaluation of topical capsaicin in pruritic psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Capsaicin; Double-Blind Method; Female; Humans; Male; Middle Aged; Pruritus; Psoriasis; Substance P | 1993 |
Uremic pruritus: roles of parathyroid hormone and substance P.
Topics: Calcium; Capsaicin; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pruritus; Renal Dialysis; Substance P | 1997 |
Treatment of prurigo nodularis with topical capsaicin.
Topics: Administration, Topical; Adult; Aged; Biopsy; Capsaicin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Prurigo; Pruritus; Substance P; Treatment Outcome | 2001 |
The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial.
Topics: Administration, Cutaneous; Animals; Capsaicin; Cross-Over Studies; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Pruritus; Substance P; Treatment Outcome | 2002 |
105 other study(ies) available for substance p and Itching
Article | Year |
---|---|
Inhibition of itch by neurokinin 1 receptor (Tacr1) -expressing ON cells in the rostral ventromedial medulla in mice.
Topics: Animals; Medulla Oblongata; Mice; Neurons; Pruritus; Receptors, Neurokinin-1; Substance P | 2022 |
Role of Type I Cannabinoid Receptor in Sensory Neurons in Psoriasiform Skin Inflammation and Pruritus.
Topics: Animals; Eczema; Imiquimod; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Pruritus; Psoriasis; Receptors, Cannabinoid; Sensory Receptor Cells; Substance P | 2023 |
Neuroimmune Mediators of Pruritus in Hispanic Scalp Psoriatic Itch.
Topics: Hispanic or Latino; Humans; Pruritus; Psoriasis; Scalp; Substance P | 2023 |
Calcium imaging of primary canine sensory neurons: Small-diameter neurons responsive to pruritogens and algogens.
Topics: Animals; Cadaver; Calcium Radioisotopes; Capsaicin; Cattle; Cells, Cultured; Chloroquine; Dogs; Ganglia, Spinal; Histamine; Humans; Laminectomy; Molecular Imaging; Neurotransmitter Agents; Pain; Peptide Fragments; Pruritus; Radiopharmaceuticals; Sensory Receptor Cells; Serotonin; Serotonin Receptor Agonists; Substance P | 2019 |
The pharmacology of itch.
Topics: Antipruritics; Humans; Pruritus; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Receptors, Neurokinin-1; Substance P | 2019 |
Are we facing a change in the treatment of chronic pruritus?
Topics: Chronic Disease; Humans; Pruritus; Receptors, Neurokinin-1; Substance P | 2019 |
PAR2, Keratinocytes, and Cathepsin S Mediate the Sensory Effects of Ciguatoxins Responsible for Ciguatera Poisoning.
Topics: Animals; Calcium; Cathepsins; Ciguatera Poisoning; Ciguatoxins; Coculture Techniques; Cytosol; Disease Models, Animal; Epidermis; Humans; Intravital Microscopy; Keratinocytes; Paresthesia; Primary Cell Culture; Pruritus; Rats; Receptor, PAR-2; Sensory Receptor Cells; Single-Cell Analysis; Substance P | 2021 |
A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antipruritics; Behavior, Animal; Biomarkers; Case-Control Studies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Female; Genetic Predisposition to Disease; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Phenotype; Pruritus; Psoriasis; Substance P; Time Factors; Up-Regulation; Young Adult | 2017 |
A single amino acid in MRGPRX2 necessary for binding and activation by pruritogens.
Topics: Arginine; Glutamic Acid; HEK293 Cells; HeLa Cells; Humans; Models, Molecular; Nerve Tissue Proteins; p-Methoxy-N-methylphenethylamine; Pruritus; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Substance P | 2017 |
TRPA1 channel participates in tacrolimus-induced pruritus in a chronic contact hypersensitivity murine model.
Topics: Administration, Cutaneous; Animals; Aprepitant; Behavior, Animal; Calcineurin Inhibitors; Dermatitis, Contact; Disease Models, Animal; Filaggrin Proteins; Ganglia, Spinal; Humans; Intermediate Filament Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Ointments; Oxazolone; Oximes; Pruritus; Skin; Substance P; Tacrolimus; TRPA1 Cation Channel | 2018 |
Substance P restores normal skin architecture and reduces epidermal infiltration of sensory nerve fiber in TNCB-induced atopic dermatitis-like lesions in NC/Nga mice.
Topics: Animals; Body Water; Cells, Cultured; Dermatitis, Atopic; Epidermis; Filaggrin Proteins; Male; Mice; Nerve Fibers; Nerve Growth Factor; Picryl Chloride; Pruritus; Semaphorin-3A; Skin; Substance P | 2018 |
Pretreatment with substance P alleviates irritation due to sodium lauryl sulphate exposure by maintaining E-cadherin expression on human keratinocytes.
Topics: Cadherins; Cell Adhesion; Cell Survival; Dermatitis, Irritant; Detergents; Humans; Keratinocytes; Neurotransmitter Agents; Pruritus; Sodium Dodecyl Sulfate; Substance P | 2018 |
Non-myelinated C-fibers, but not myelinated A-fibers, elongate into the epidermis in dry skin with itch.
Topics: Animals; Calcitonin Gene-Related Peptide; Epidermis; Male; Mice; Mice, Inbred ICR; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Pruritus; Skin; Substance P | 2018 |
Pathophysiologic mechanisms of itch in bullous pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Basophils; Cell Adhesion Molecules; Chronic Disease; Cytokines; Eosinophils; Female; Fluorescent Antibody Technique; Humans; Interleukin-13; Male; Middle Aged; Oncostatin M Receptor beta Subunit; Pemphigoid, Bullous; Pruritus; Receptors, Interleukin; Receptors, Neurokinin-1; Severity of Illness Index; Skin; Substance P; Th2 Cells | 2020 |
Excitatory superficial dorsal horn interneurons are functionally heterogeneous and required for the full behavioral expression of pain and itch.
Topics: Animals; Cell Death; Cognition Disorders; Disease Models, Animal; Glutamate Decarboxylase; Green Fluorescent Proteins; Hyperalgesia; Interneurons; Lectins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oncogene Proteins v-fos; Pain; Pain Threshold; Phosphopyruvate Hydratase; Pruritus; Reaction Time; Receptors, Steroid; Receptors, Thyroid Hormone; Spinal Nerve Roots; Substance P | 2013 |
Substance P and intensity of pruritus in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Calcium; Enzyme-Linked Immunosorbent Assay; Female; Ferritins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Nephelometry and Turbidimetry; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Pruritus; Renal Dialysis; Statistics, Nonparametric; Substance P | 2013 |
Roles of glutamate, substance P, and gastrin-releasing peptide as spinal neurotransmitters of histaminergic and nonhistaminergic itch.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Antirheumatic Agents; Bombesin; Chloroquine; Drug Combinations; Excitatory Amino Acid Antagonists; Ganglia, Spinal; Gastrin-Releasing Peptide; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Neurons; Peptide Fragments; Piperidines; Pruritus; Substance P; Vesicular Glutamate Transport Protein 2 | 2014 |
An amino-terminal fragment of hemokinin-1 has an inhibitory effect on pruritic processing in rats.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Drug Administration Routes; Injections, Spinal; Male; Pain Measurement; Peptide Fragments; Proto-Oncogene Proteins c-fos; Pruritus; Rats; Rats, Sprague-Dawley; Substance P; Tachykinins; Time Factors | 2014 |
Topical non-peptide antagonists of sensory neurotransmitters substance P and CGRP do not modify patch test and prick test reactions: a vehicle-controlled, double-blind pilot study.
Topics: Adult; Aged; Antipruritics; Aprepitant; Azepines; Calcitonin Gene-Related Peptide; Dermatitis, Contact; Double-Blind Method; Female; Humans; Hypersensitivity, Delayed; Imidazoles; Male; Middle Aged; Morpholines; Nickel; Permeability; Pilot Projects; Pruritus; Skin; Skin Physiological Phenomena; Skin Tests; Substance P; Urticaria; Vasoconstriction; Water Loss, Insensible; Young Adult | 2014 |
Increased expression of three types of transient receptor potential channels (TRPA1, TRPV4 and TRPV3) in burn scars with post-burn pruritus.
Topics: Adolescent; Adult; Biopsy; Burns; Calcitonin Gene-Related Peptide; Calcium Channels; Child; Cicatrix; Epidermis; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nerve Tissue Proteins; Pruritus; Real-Time Polymerase Chain Reaction; RNA, Messenger; Substance P; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels; Young Adult | 2015 |
Immunohistochemical analysis of neuropeptides (protein gene product 9.5, substance P and calcitonin gene-related peptide) in hypertrophic burn scar with pain and itching.
Topics: Adult; Burns; Calcitonin Gene-Related Peptide; Case-Control Studies; Cicatrix, Hypertrophic; Female; Humans; Immunohistochemistry; Male; Middle Aged; Pain; Pruritus; Skin; Substance P; Ubiquitin Thiolesterase | 2014 |
Hemokinin-1 mediates pruriceptive processing in the rat spinal cord.
Topics: Animals; Disease Models, Animal; Formaldehyde; Histamine; Immunohistochemistry; Male; Nociception; Pain; Proto-Oncogene Proteins c-fos; Pruritus; Rats, Sprague-Dawley; Serotonin; Spinal Cord; Substance P; Tachykinins | 2014 |
Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour.
Topics: Administration, Oral; Animals; Antipruritics; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Pruritus; Substance P | 2014 |
Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice.
Topics: Allergens; Animals; Cell Degranulation; Collagen; Dinitrofluorobenzene; Disease Models, Animal; Eosinophilia; Eosinophils; Fibrosis; Inflammation; Mice; Phthalic Anhydrides; Pruritus; Skin; Substance P | 2015 |
Multimodal use of calcitonin gene-related peptide and substance P in itch and acute pain uncovered by the elimination of vesicular glutamate transporter 2 from transient receptor potential cation channel subfamily V member 1 neurons.
Topics: Acute Pain; Animals; Calcitonin Gene-Related Peptide; Female; Male; Mice; Mice, Transgenic; Neurons; Pain Measurement; Pruritus; Substance P; TRPV Cation Channels; Vesicular Glutamate Transport Protein 2 | 2014 |
The NK1 receptor antagonist aprepitant attenuates NK1 agonist-induced scratching behaviour in the gerbil after intra-dermal, topical or oral administration.
Topics: Administration, Oral; Administration, Topical; Animals; Antipruritics; Aprepitant; Disease Models, Animal; Drug Evaluation, Preclinical; Gerbillinae; Humans; Injections, Intradermal; Morpholines; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Pruritus; Receptors, Neurokinin-1; Substance P | 2015 |
S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission.
Topics: Animals; Behavior, Animal; Female; Ganglia, Spinal; Histamine; Mice, Inbred ICR; Neurons; p-Methoxy-N-methylphenethylamine; Pruritus; Pyridones; Rats, Inbred F344; Receptor, Cannabinoid, CB2; Serotonin; Signal Transduction; Substance P | 2015 |
Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.
Topics: Animals; Behavior, Animal; Catheterization; Cisterna Magna; Female; Injections, Spinal; Lumbosacral Region; Macaca mulatta; Male; Morphine; Nociceptin; Nociceptin Receptor; Opioid Peptides; Pain; Pruritus; Receptors, Opioid; Substance P | 2015 |
Differential Changes in the Peptidergic and the Non-Peptidergic Skin Innervation in Rat Models for Inflammation, Dry Skin Itch, and Dermatitis.
Topics: Acetone; Animals; Biopsy; Calcitonin Gene-Related Peptide; Dermatitis; Dinitrochlorobenzene; Disease Models, Animal; Freund's Adjuvant; Inflammation; Male; Nerve Fibers; Pruritus; Rats; Rats, Wistar; Receptors, Purinergic P2X3; Skin; Substance P | 2015 |
Critical evaluation of the expression of gastrin-releasing peptide in dorsal root ganglia and spinal cord.
Topics: Amino Acid Sequence; Animals; Antibody Specificity; Cell Count; Cells, Cultured; Chronic Disease; Ganglia, Spinal; Gastrin-Releasing Peptide; Gene Deletion; Gene Expression Regulation; Male; Mice, Inbred C57BL; Mice, Knockout; Posterior Horn Cells; Pruritus; Receptors, Bombesin; RNA, Messenger; Spinal Cord; Substance P | 2016 |
Dual action of neurokinin-1 antagonists on Mas-related GPCRs.
Topics: Animals; Cell Degranulation; Cell Line; HEK293 Cells; HeLa Cells; Humans; Mast Cells; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurokinin-1 Receptor Antagonists; Pruritus; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Substance P | 2016 |
Dihydroavenanthramide D inhibits mast cell degranulation and exhibits anti-inflammatory effects through the activation of neurokinin-1 receptor.
Topics: Animals; Calcium Signaling; Cell Line; Chronic Disease; Drug Evaluation, Preclinical; Humans; Mast Cells; ortho-Aminobenzoates; Pruritus; Rats; Receptors, Neurokinin-1; Substance P | 2017 |
Substance P activates Mas-related G protein-coupled receptors to induce itch.
Topics: Adolescent; Adult; Aged; Animals; Capsaicin; Cells, Cultured; Female; Ganglia, Spinal; Humans; Male; Mice, Transgenic; Middle Aged; Pruritus; Receptors, G-Protein-Coupled; Receptors, Neurokinin-1; Sensory Receptor Cells; Substance P; Young Adult | 2017 |
Distribution of hemokinin-1 in the rat trigeminal ganglion and trigeminal sensory nuclear complex.
Topics: Amino Acid Sequence; Animals; Antigens, Nuclear; Brain Stem; Guinea Pigs; Immunohistochemistry; Male; Nerve Tissue Proteins; Neurons; Pain; Pruritus; Rabbits; Rats; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Substance P; Tachykinins; Trigeminal Caudal Nucleus; Trigeminal Ganglion | 2017 |
Investigation of the pruritogenic effects of histamine, serotonin, tryptase, substance P and interleukin-2 in healthy dogs.
Topics: Analgesics, Non-Narcotic; Animals; Dog Diseases; Dogs; Female; Histamine; Histamine Agonists; Interleukin-2; Neurotransmitter Agents; Pruritus; Serotonin; Serotonin Agents; Substance P; Tryptases | 2009 |
Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.
Topics: Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Hyperalgesia; Injections, Spinal; Macaca mulatta; Male; Morphine; Nociceptin; Opioid Peptides; Pain Measurement; Pruritus; Receptors, Opioid; Substance P | 2009 |
Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist.
Topics: Animals; Disease Models, Animal; Epidermis; Histamine; Histamine Antagonists; Humans; Indoles; Keratinocytes; Male; Mice; Mice, Inbred ICR; Piperazines; Pruritus; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Substance P | 2009 |
Olopatadine hydrochloride inhibits scratching behavior induced by a proteinase-activated receptor 2 agonist in mice.
Topics: Animals; Antipruritics; Behavior, Animal; Dibenzoxepins; Disease Models, Animal; Dose-Response Relationship, Drug; Mice; Mice, Inbred C57BL; Oligopeptides; Olopatadine Hydrochloride; Protein Precursors; Pruritus; Receptor, PAR-2; RNA, Messenger; Substance P; Tachykinins; Time Factors | 2009 |
Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus.
Topics: Animals; Behavior, Animal; Dermatitis, Atopic; Dexamethasone; Ear; Male; Mice; Mice, Inbred BALB C; Pruritus; Substance P; Tacrolimus | 2010 |
Differential effects of substance P or hemokinin-1 on transient receptor potential channels, TRPV1, TRPA1 and TRPM8, in the rat.
Topics: Acrolein; Animals; Ankyrins; Behavior, Animal; Calcium Channels; Diterpenes; Injections, Spinal; Male; Menthol; Pruritus; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P; Tachykinins; TRPA1 Cation Channel; TRPC Cation Channels; TRPM Cation Channels; TRPV Cation Channels | 2010 |
Effect of epinastine hydrochloride on murine self-scratching behavior after skin-scratching stimulation.
Topics: Administration, Oral; Animals; Behavior Control; Cell Degranulation; Dibenzazepines; Histamine H1 Antagonists, Non-Sedating; Imidazoles; Immunohistochemistry; Mast Cells; Mice; Mice, Inbred ICR; Nerve Growth Factor; Pruritus; Sensory Receptor Cells; Skin Diseases; Substance P | 2010 |
Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats.
Topics: Animals; Drug Combinations; Hindlimb; Immunohistochemistry; Injections, Intradermal; Male; Microinjections; Neurotransmitter Agents; Posterior Horn Cells; Pruritus; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Ribosome Inactivating Proteins, Type 1; Saporins; Serotonin; Serotonin Agents; Substance P | 2010 |
Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
Topics: Adrenergic Fibers; Adult; Aged; Aged, 80 and over; Biopsy; Chronic Disease; Dermatitis, Atopic; Dermis; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Prurigo; Pruritus; Sensory Receptor Cells; Substance P | 2010 |
Inhibitory effect of methanol extract of Ganoderma lucidum on acute itch-associated responses in mice.
Topics: Afferent Pathways; Animals; Behavior, Animal; Biological Products; Dose-Response Relationship, Drug; Histamine; Male; Mice; Mice, Inbred ICR; Oligopeptides; p-Methoxy-N-methylphenethylamine; Phytotherapy; Pruritus; Receptor, PAR-2; Receptors, Serotonin; Reishi; Serotonin; Skin; Substance P | 2010 |
Absence of histamine-induced itch in the African naked mole-rat and "rescue" by Substance P.
Topics: Animals; Calcium; Histamine; Male; Mice; Mice, Inbred C57BL; Mole Rats; Posterior Horn Cells; Pruritus; Rats; Spinal Cord; Substance P | 2010 |
Association of stress with symptoms of atopic dermatitis.
Topics: Adolescent; Adult; Anxiety; Biopsy; Case-Control Studies; Child; Depression; Dermatitis, Atopic; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nerve Growth Factor; Neuropeptide Y; Prognosis; Pruritus; Quality of Life; Receptors, Corticotropin-Releasing Hormone; Republic of Korea; Severity of Illness Index; Skin; Stress, Psychological; Substance P; Surveys and Questionnaires; Young Adult | 2010 |
More on aprepitant for erlotinib-induced pruritus.
Topics: Antiemetics; Aprepitant; Erlotinib Hydrochloride; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Off-Label Use; Protein Kinase Inhibitors; Pruritus; Quinazolines; Substance P | 2011 |
Topical cholecystokinin depresses itch-associated scratching behavior in mice.
Topics: Administration, Topical; Animals; Behavior, Animal; Calcium; Cell Degranulation; Chemokines, CC; Cholagogues and Choleretics; Cholecystokinin; Dermis; Female; Gene Expression; Keratinocytes; Mast Cells; Mice; Mice, Inbred ICR; Neurotransmitter Agents; Pruritus; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Substance P | 2011 |
Maropitant citrate for treatment of ulcerative dermatitis in mice with a C57BL/6 background.
Topics: Animals; Antipruritics; Dermatitis; Female; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Pruritus; Quinuclidines; Rodent Diseases; Skin Ulcer; Substance P | 2011 |
Glycyrrhetinic acid prevents cutaneous scratching behavior in mice elicited by substance P or PAR-2 agonist.
Topics: Animals; Antipruritics; Behavior, Animal; Glycyrrhetinic Acid; Histamine; Leukotriene B4; Male; Mice; Mice, Inbred ICR; Pruritus; Receptor, PAR-2; Skin; Substance P | 2011 |
The feeling of healing.
Topics: Cicatrix; Humans; Neurotransmitter Agents; Pruritus; Sensation; Substance P; Wound Healing | 2012 |
Do acupuncture meridians exist? Correlation with referred itch (mitempfindung) stimulus and referral points.
Topics: Acupuncture Points; Acupuncture Therapy; Humans; Male; Mast Cells; Meridians; Merkel Cells; Pain, Referred; Pruritus; Substance P | 2012 |
Expression of selected neuropeptides in pathogenesis of bullous pemphigoid and dermatitis herpetiformis.
Topics: Aged; Aged, 80 and over; Calcitonin Gene-Related Peptide; Corticotropin-Releasing Hormone; Dermatitis Herpetiformis; Female; Humans; Immunohistochemistry; Male; Middle Aged; Neurokinin B; Neuropeptides; Pemphigoid, Bullous; Pruritus; Receptor, Endothelin B; Substance P | 2012 |
Investigation of serum substance P status in patients with chronic pruritic skin lesions due to sulfur mustard: a cross-sectional study.
Topics: Adult; Cross-Sectional Studies; Dermatitis, Atopic; Humans; Iraq; Male; Middle Aged; Mustard Gas; Pruritus; Quality of Life; Substance P; Veterans | 2013 |
Artemin causes hypersensitivity to warm sensation, mimicking warmth-provoked pruritus in atopic dermatitis.
Topics: Animals; Cell Differentiation; Cell Proliferation; Dermatitis, Atopic; Female; Hot Temperature; Humans; Hyperalgesia; Hypersensitivity; Immunohistochemistry; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Nerve Tissue Proteins; Neurites; Pruritus; Sensory Thresholds; Skin; Substance P; TRPV Cation Channels | 2012 |
In vitro and in vivo pharmacological characterization of the main metabolites of nalfurafine hydrochloride.
Topics: Animals; Antipruritics; Behavior, Animal; HEK293 Cells; Humans; Male; Mice; Morphinans; Pruritus; Receptors, Opioid; Spiro Compounds; Substance P | 2012 |
Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients.
Topics: Adult; Brain-Derived Neurotrophic Factor; Calcitonin Gene-Related Peptide; Corticotropin-Releasing Hormone; Female; Humans; Interleukins; Male; Middle Aged; Pruritus; Psoriasis; Skin; Substance P; Surveys and Questionnaires; Ultraviolet Rays; Ultraviolet Therapy | 2013 |
Roles for substance P and gastrin-releasing peptide as neurotransmitters released by primary afferent pruriceptors.
Topics: Animals; Calcium; Chloroquine; Ganglia, Spinal; Gastrin-Releasing Peptide; Histamine; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Oligopeptides; Peptide Fragments; Pruritus; Receptors, Bombesin; Sensory Receptor Cells; Serotonin; Signal Transduction; Substance P | 2013 |
Nitric oxide enhances substance P-induced itch-associated responses in mice.
Topics: Adult; Animals; Enzyme Inhibitors; Humans; Male; Mice; Mice, Inbred ICR; Neurokinin-1 Receptor Antagonists; Nitric Oxide; Nitric Oxide Synthase; Pruritus; Receptors, Neurokinin-1; Substance P | 2003 |
Deletion of the preprotachykinin A gene in mice does not reduce scratching behavior elicited by intradermal serotonin.
Topics: Animals; Injections, Intradermal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Precursors; Pruritus; Serotonin; Substance P; Synaptic Transmission; Tachykinins | 2003 |
[Antipruritic effects of pimecrolimus and tacrolimus].
Topics: Administration, Topical; Animals; Antipruritics; Calcineurin Inhibitors; Dermatitis, Allergic Contact; Humans; Immunosuppressive Agents; Mast Cells; Microscopy, Fluorescence; Neuropeptides; Pruritus; Skin; Substance P; Tacrolimus; Treatment Outcome | 2003 |
Inhibitory effect of the repeated treatment with Unsei-in on substance P-induced itch-associated responses through the downregulation of the expression of NK(1) tachykinin receptor in mice.
Topics: Administration, Oral; Animals; Antipruritics; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Injections, Intradermal; Male; Mice; Mice, Inbred ICR; Pruritus; Receptors, Neurokinin-1; Skin; Substance P | 2003 |
Involvement of histamine H3 receptors in scratching behaviour in mast cell-deficient mice.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Female; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Injections, Intradermal; Mast Cells; Mice; Mice, Inbred Strains; Pruritus; Receptors, Histamine H3; Skin; Substance P | 2003 |
Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.
Topics: Animals; Antipruritics; Behavior, Animal; Injections, Intraventricular; Injections, Subcutaneous; Ketotifen; Male; Mice; Morphinans; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spiro Compounds; Substance P | 2003 |
Repeated treatment with the traditional medicine Unsei-in inhibits substance P-induced itch-associated responses through downregulation of the expression of nitric oxide synthase 1 in mice.
Topics: Animals; Dose-Response Relationship, Drug; Down-Regulation; Drugs, Chinese Herbal; Gene Expression Regulation, Enzymologic; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pruritus; Substance P | 2004 |
Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.
Topics: Adolescent; Adult; Aged; Animals; Biopsy; Brain; Calcitonin Gene-Related Peptide; Capillaries; Capsaicin; Cell Line; Child; Eccrine Glands; Epidermal Cells; Epidermis; Epithelial Cells; Gene Expression; Hair Follicle; Humans; Mast Cells; Middle Aged; Nerve Fibers; Neurons, Afferent; Nociceptors; Pruritus; Rats; Receptors, Drug; Sebaceous Glands; Spinal Cord; Substance P | 2004 |
Substance P axons and sensory threshold increase in burn-graft human skin.
Topics: Adult; Axons; Burns; Dermatologic Surgical Procedures; Humans; Middle Aged; Nerve Regeneration; Nociceptors; Pain; Pruritus; Recovery of Function; Sensory Thresholds; Skin; Skin Transplantation; Substance P; Touch; Vibration | 2004 |
Involvement of substance P in scratching behaviour in an atopic dermatitis model.
Topics: Animals; Behavior, Animal; Dermatitis, Atopic; Disease Models, Animal; Male; Mice; Neurokinin-1 Receptor Antagonists; Pruritus; Receptors, Neurokinin-1; Substance P; Tachykinins | 2004 |
Inhibition of scratching behaviour caused by contact dermatitis in histidine decarboxylase gene knockout mice.
Topics: Animals; Behavior, Animal; Cadherins; Dermatitis, Contact; Histamine; Histidine Decarboxylase; Mice; Mice, Knockout; Neural Conduction; Proto-Oncogene Proteins c-fos; Pruritus; Sensation; Spinal Cord; Substance P | 2005 |
Pruritus after intrathecal baclofen withdrawal: A retrospective study.
Topics: Baclofen; GABA Agonists; Humans; Incidence; Infusion Pumps, Implantable; Injections, Spinal; Muscle Spasticity; Pruritus; Retrospective Studies; Substance P; Substance Withdrawal Syndrome | 2005 |
Antipruritic effect of ginsenoside rb1 and compound k in scratching behavior mouse models.
Topics: Animals; Antipruritics; Behavior, Animal; Capillary Permeability; Disease Models, Animal; Ginsenosides; Histamine; Inhibitory Concentration 50; Male; Mice; p-Methoxy-N-methylphenethylamine; Phthalazines; Pruritus; Substance P; Time Factors | 2005 |
Role of substance P on histamine H(3) antagonist-induced scratching behavior in mice.
Topics: Amphetamines; Animals; Behavior, Animal; Histamine Antagonists; Imidazoles; Isothiuronium; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Pruritus; Receptors, Histamine H1; Receptors, Histamine H3; Substance P | 2006 |
Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch.
Topics: Adult; Bradykinin; Cross-Over Studies; Dermatitis, Atopic; Female; Histamine; Histamine H1 Antagonists; Humans; Iontophoresis; Male; Pain; Pruritus; Serotonin; Single-Blind Method; Substance P; Urticaria; Water | 2006 |
Suppression by bepotastine besilate of substance P-induced itch-associated responses through the inhibition of the leukotriene B4 action in mice.
Topics: Administration, Oral; Animals; Behavior, Animal; Calcium; Dose-Response Relationship, Drug; Ganglia, Spinal; Histamine H1 Antagonists; Leukotriene B4; Male; Mice; Mice, Inbred ICR; Neurons; Neutrophils; Piperidines; Pruritus; Pyridines; Skin; Substance P | 2006 |
How important are NK1 receptors for influencing microvascular inflammation and itch in the skin? Studies using Phoneutria nigriventer venom.
Topics: Administration, Topical; Animals; Dose-Response Relationship, Drug; Edema; Female; Injections, Intradermal; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Piperidines; Pruritus; Quinuclidines; Receptors, Neurokinin-1; Skin; Spider Venoms; Substance P; Vasculitis, Leukocytoclastic, Cutaneous | 2006 |
Neuronal conditions of spinal cord in dermatitis are improved by olopatadine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cyclopropanes; Dermatitis, Contact; Dibenzoxepins; Dose-Response Relationship, Drug; Eczema; Female; Histamine H1 Antagonists; Immunohistochemistry; Mice; Mice, Inbred BALB C; Neurons; Olopatadine Hydrochloride; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Pruritus; Skin; Substance P | 2006 |
Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.
Topics: Animals; Brain; CD4-Positive T-Lymphocytes; Chronic Disease; Dermatitis; Dermis; Epidermis; Female; Gene Expression; Homeostasis; Hypertrophy; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Endings; Pruritus; Receptors, Opioid, kappa; Receptors, Opioid, mu; RNA, Messenger; Substance P; Ubiquitin Thiolesterase | 2007 |
Changes in cutaneous sensory nerve fibers induced by skin-scratching in mice.
Topics: Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Dermis; Epidermis; Fluorescent Antibody Technique; Male; Mice; Mice, Inbred ICR; Pruritus; Sensory Receptor Cells; Signal Transduction; Substance P; Ubiquitin Thiolesterase | 2007 |
Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Topics: Adult; Aged; Chronic Disease; Female; Gene Expression Regulation; Humans; Hydrocortisone; Male; Middle Aged; Pain Measurement; Pruritus; Psoriasis; Receptors, Neurokinin-1; Saliva; Skin; Stress, Psychological; Substance P | 2007 |
Psychological stress can trigger atopic dermatitis in NC/Nga mice: an inhibitory effect of corticotropin-releasing factor.
Topics: Animals; Antibodies, Blocking; Corticosterone; Corticotropin-Releasing Hormone; Cytokines; Defecation; Dermatitis, Atopic; Immunoglobulin E; Immunohistochemistry; Lymph Nodes; Male; Mice; Pruritus; Stress, Psychological; Substance P; Water | 2008 |
Dietary pulverized konjac glucomannan suppresses scratching behavior and skin inflammatory immune responses in NC/Nga mice.
Topics: Animals; Dermatitis, Atopic; Dietary Carbohydrates; Disease Models, Animal; Ear; Eosinophilia; Immunoglobulin E; Immunoglobulin G; Interferon-alpha; Interleukin-10; Interleukin-4; Keratosis; Male; Mannans; Mastocytosis, Cutaneous; Mice; Mice, Inbred Strains; Pruritus; Skin; Substance P | 2007 |
Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice.
Topics: Animals; Cell Degranulation; Dermatitis, Contact; Dinitrofluorobenzene; Male; Mast Cells; Mice; Mice, Inbred ICR; Neprilysin; Neurokinin-1 Receptor Antagonists; Physical Stimulation; Pruritus; Receptors, Neurokinin-1; Skin; Skin Physiological Phenomena; Substance P | 2007 |
A transient unresponsive state of self-scratching behaviour is induced in mice by skin-scratching stimulation.
Topics: Analgesics, Non-Narcotic; Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Capsaicin; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Peptide Fragments; Physical Stimulation; Pruritus; Quinuclidines; Self Stimulation; Signal Transduction; Skin Physiological Phenomena; Substance P | 2007 |
Erratum to "changes in cutaneous sensory nerve fibers induced by skin-scratching in mice".
Topics: Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Dermis; Epidermis; Fluorescent Antibody Technique; Male; Mice; Mice, Inbred ICR; Nerve Fibers; Nerve Growth Factor; Neurons, Afferent; Pruritus; Sensory Receptor Cells; Signal Transduction; Substance P; Ubiquitin Thiolesterase | 2007 |
Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P.
Topics: Brain-Derived Neurotrophic Factor; Chemokines; Child; Dermatitis, Atopic; Eosinophils; Female; Humans; Immunoglobulin E; Male; Pruritus; Quality of Life; Severity of Illness Index; Sleep; Substance P | 2007 |
The role of selected neuropeptides in pathogenesis of atopic dermatitis.
Topics: Adolescent; Adult; Calcitonin Gene-Related Peptide; Case-Control Studies; Dermatitis, Atopic; Female; Humans; Immunoglobulin E; Inflammation; Male; Middle Aged; Neuropeptide Y; Pain Measurement; Pruritus; Severity of Illness Index; Skin; Substance P | 2008 |
Effects of topical application of tacrolimus on acute itch-associated responses in mice.
Topics: Administration, Topical; Aedes; Animals; Antipruritics; Behavior, Animal; Capsaicin; Female; Histamine; Immunosuppressive Agents; Male; Mice; Mice, Inbred ICR; Pruritus; Serotonin; Substance P; Tacrolimus | 2008 |
Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK-33-824, beta-endorphin and morphine.
Topics: Adolescent; Adult; beta-Endorphin; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Dinoprostone; Drug Synergism; Endorphins; Enkephalin, Methionine; Female; Histamine; Humans; Indomethacin; Male; Middle Aged; Morphine; Naloxone; Prostaglandins E; Pruritus; Skin; Substance P; Vasoactive Intestinal Peptide | 1982 |
Peptidergic (neurotensin, VIP, substance P) nerve fibres in the skin. Immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus and inflammation.
Topics: Animals; Arteries; Cats; Dermatitis; Dogs; Gastrointestinal Hormones; Guinea Pigs; Haplorhini; Humans; Nerve Fibers; Neurotensin; Nociceptors; Pruritus; Rats; Skin; Substance P; Vasoactive Intestinal Peptide; Veins | 1983 |
Influence of calcitonin gene-related peptide on histamine- and substance P-induced itch, flare and weal in humans.
Topics: Adult; Calcitonin Gene-Related Peptide; Dermatitis, Contact; Female; Histamine; Humans; Injections, Subcutaneous; Male; Pruritus; Substance P | 1993 |
Scratching behavior induced by pruritogenic but not algesiogenic agents in mice.
Topics: Animals; Behavior, Animal; Capsaicin; Formaldehyde; Histamine; Male; Mice; p-Methoxy-N-methylphenethylamine; Pain; Pruritus; Substance P | 1995 |
Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Cold Temperature; Dermatitis, Atopic; Female; Forearm; Histamine; Humans; Injections, Intradermal; Iontophoresis; Male; Middle Aged; Neurons, Afferent; Pruritus; Scapula; Skin; Skin Temperature; Substance P | 1995 |
Pruritogenic effects of mitogen-stimulated peripheral blood mononuclear cells in atopic eczema.
Topics: Adult; Cells, Cultured; Concanavalin A; Cytokines; Dermatitis, Atopic; Histamine; Humans; Leukocytes, Mononuclear; Mitogens; Phytohemagglutinins; Pruritus; Substance P | 1995 |
Clinical and pathophysiological aspects of hydroxyethyl starch-induced pruritus: evaluation of 96 cases.
Topics: Biopsy, Needle; Drug Eruptions; Humans; Hydroxyethyl Starch Derivatives; Infusions, Intravenous; Patch Tests; Plasma Substitutes; Prospective Studies; Pruritus; Radioimmunoassay; Retrospective Studies; Substance P | 1996 |
Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice.
Topics: Animals; Male; Mast Cells; Mice; Mice, Inbred ICR; Morphine; Naloxone; p-Methoxy-N-methylphenethylamine; Pruritus; Receptors, Neurokinin-1; Substance P | 1998 |
Inhibitory effects of methanol extracts of herbal medicines on substance P-induced itch-scratch response.
Topics: Animals; Antipruritics; Disease Models, Animal; Male; Methanol; Mice; Mice, Inbred ICR; Phytotherapy; Plants, Medicinal; Pruritus; Substance P | 2000 |
Involvement of blockade of leukotriene B(4) action in anti-pruritic effects of emedastine in mice.
Topics: Animals; Anti-Allergic Agents; Benzimidazoles; Dose-Response Relationship, Drug; Histamine; Injections, Intradermal; Leukotriene B4; Male; Mice; Mice, Inbred ICR; Pruritus; Serotonin; Substance P | 2000 |
Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis.
Topics: Animals; Attention; Chronic Disease; Dermatitis; Female; Histamine; Immunoglobulin E; Mice; Mice, Inbred Strains; Mites; Naltrexone; Narcotic Antagonists; Pruritus; Serotonin; Substance P | 2001 |
Intradermal skin test reactivity to histamine and substance P is blunted in dogs with atopic dermatitis.
Topics: Animals; Case-Control Studies; Dermatitis, Atopic; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Histamine; Intradermal Tests; Male; Pruritus; Skin; Substance P; Time Factors | 2001 |
Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.
Topics: Animals; Antipruritics; Chlorpheniramine; Disease Models, Animal; Histamine; Histamine H1 Antagonists; Ketotifen; Male; Mice; Mice, Inbred ICR; Morphinans; Motor Activity; Naltrexone; Pruritus; Receptors, Opioid, kappa; Spiro Compounds; Substance P | 2002 |
Inhibitory effects of azelastine on substance P-induced itch-associated response in mice.
Topics: Animals; Anti-Allergic Agents; Behavior, Animal; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Histamine; Histamine H1 Antagonists; Leukotriene B4; Male; Mice; Mice, Inbred ICR; Neutrophils; Phthalazines; Pruritus; Skin; Substance P | 2002 |
Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Enzyme Inhibitors; Glucocorticoids; Immunosuppressive Agents; Indomethacin; Keratinocytes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mast Cells; Mice; Mice, Inbred ICR; Mice, Mutant Strains; Phenylpropionates; Phospholipases A; Pruritus; Receptors, Leukotriene B4; Receptors, Neurokinin-1; Substance P | 2001 |
Immunohistochemical findings in notalgia paresthetica.
Topics: Adult; Aged; Back Pain; Biomarkers; Epidermis; Female; Humans; Hyperpigmentation; Immunohistochemistry; Male; Middle Aged; Polyradiculoneuropathy; Pruritus; S100 Proteins; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 2002 |
Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin: plasma levels of substance P, somatostatin, IgE, PTH and histamine.
Topics: Adjuvants, Immunologic; Female; Histamine; Humans; Immunoglobulin E; Male; Middle Aged; Parathyroid Hormone; Polysaccharides; Pruritus; Renal Dialysis; Somatostatin; Substance P | 1990 |
Nasal challenge with serotonin in asymptomatic hay fever patients.
Topics: Adult; Airway Resistance; Female; Humans; Male; Mucus; Nasal Mucosa; Nasal Provocation Tests; Pruritus; Rhinitis, Allergic, Seasonal; Serotonin; Sneezing; Substance P | 1987 |